Published in Can J Physiol Pharmacol on September 01, 1973
Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol (1982) 2.22
Structure-activity studies on bradykinin and related peptides: agonists. Br J Pharmacol (1990) 0.87
Mechanism of decreased vascular reactivity to angiotensin II in conscious, potassium-deficient rats. J Clin Invest (1984) 0.78
Pharmacology of bradykinin and related kinins. Pharmacol Rev (1980) 8.11
Pharmacology of angiotensin. Pharmacol Rev (1974) 2.25
Guillain-Barré syndrome: MR imaging findings of the spine in eight patients. Radiology (1998) 2.08
Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol (2000) 1.97
New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends Pharmacol Sci (1988) 1.83
Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol (1985) 1.64
Selective agonists for substance P and neurokinin receptors. Neuropeptides (1987) 1.51
Pharmacological receptors for substance P and neurokinins. Life Sci (1987) 1.50
Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin). Eur J Pharmacol (1992) 1.50
Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin-induced contractions of guinea-pig isolated trachea. Br J Pharmacol (1988) 1.49
Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol (1983) 1.47
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol (2008) 1.46
De novo formation of vascular receptors for bradykinin. Can J Physiol Pharmacol (1978) 1.45
The continuous estimation of angiotensin formed in the circulation of the dog. J Physiol (1966) 1.41
A new selective antagonist of the nociceptin receptor. Br J Pharmacol (1998) 1.41
An analysis of the negative inotropic action of somatostatin. Br J Pharmacol (1979) 1.37
Receptors for bradykinin in rabbit aortae. Can J Physiol Pharmacol (1977) 1.37
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem (1997) 1.36
The actions of kinin antagonists on B1 and B2 receptor systems. Eur J Pharmacol (1986) 1.31
Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Br J Pharmacol (1990) 1.26
Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur J Pharmacol (1986) 1.24
Receptors for substance P. I. The pharmacological preparations. Eur J Pharmacol (1984) 1.24
Rat vas deferens: a specific bioassay for endogenous opioid peptides. Br J Pharmacol (1978) 1.24
Relative potencies of neurokinins in guinea pig trachea and human bronchus. Eur J Pharmacol (1987) 1.22
The vasoconstrictor effect of neuropeptide Y and related peptides in the guinea pig isolated heart. Peptides (1986) 1.18
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol (2000) 1.18
Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem Biophys Res Commun (1992) 1.17
Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl) (1999) 1.17
Characterization of neurokinin receptors in various isolated organs by the use of selective agonists. Life Sci (1987) 1.14
Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study. J Urol (2001) 1.12
Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin. J Pharmacol Exp Ther (1994) 1.11
Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun (1991) 1.10
Biological activity of N-terminal fragments of calcitonin gene-related peptide. Eur J Pharmacol (1990) 1.10
Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system. J Cardiovasc Pharmacol (1984) 1.10
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.08
Cardiovascular actions of kinins in the rabbit. Can J Physiol Pharmacol (1979) 1.08
The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur J Pharmacol (1987) 1.08
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol (2000) 1.08
Receptors for kinins in isolated arterial vessels of dogs. Eur J Pharmacol (1989) 1.07
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol (1998) 1.07
Peptides and the human colon: an in vitro pharmacological study. Can J Physiol Pharmacol (1981) 1.05
Kinin receptors in experimental inflammation. Can J Physiol Pharmacol (1980) 1.05
Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension (1998) 1.05
Pressor action of beta blocking agents in rats. Can J Physiol Pharmacol (1970) 1.03
Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins. Pharmacology (1986) 1.03
Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis (1989) 1.03
Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. J Auton Pharmacol (1987) 1.02
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem (1998) 1.02
Nociceptin/orphanin FQ receptor ligands. Peptides (2000) 1.02
Structure-activity studies of neurokinin A. Neuropeptides (1989) 1.01
Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells. J Pharmacol Exp Ther (1990) 1.01
Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation. J Pharmacol Exp Ther (1992) 1.01
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur J Pharmacol (1996) 1.00
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.00
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor. J Med Chem (2000) 1.00
A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan. Eur J Pharmacol (1990) 0.99
Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists. Hypertension (1991) 0.99
Synthesis of [5-isoleucine, 8-alanine]-angiotensin II by the solution method synthesis and the solid-phase method synthesis. Biochemistry (1967) 0.99
Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins. Am J Physiol Lung Cell Mol Physiol (2001) 0.99
Effects of vasoactive agents in healthy and diseased human saphenous veins. J Vasc Surg (1998) 0.98
The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system. J Neurochem (1982) 0.98
Synthetic C5a receptor agonists. Pharmacology, metabolism and in vivo cardiovascular and hematologic effects. Biochem Pharmacol (1993) 0.98
Structure-activity studies of B1 receptor-related peptides. Antagonists. Hypertension (1996) 0.97
Site of action of angiotensin and other vasoconstrictors on the kidney. Can J Physiol Pharmacol (1971) 0.97
The stimulatory effects of neurotensin and related peptides in rat stomach strips and guinea-pig atria. Br J Pharmacol (1980) 0.97
Peptides and histamine release from rat peritoneal mast cells. Eur J Pharmacol (1985) 0.97
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptors. J Auton Pharmacol (1991) 0.97
Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor. Br J Pharmacol (1993) 0.96
Prerequisites for the natriuretic effect of val-5-angiotensin II amide in the rat. Am J Physiol (1968) 0.96
Interleukin-6 secretion from human astrocytoma cells induced by substance P. J Neuroimmunol (1994) 0.96
Antagonists for the neurokinin NK-3 receptor evaluated in selective receptor systems. Regul Pept (1990) 0.96
Specific agonists for neurokinin B receptors. Eur J Pharmacol (1987) 0.96
A reexamination of the role of GABA in the mammalian suprachiasmatic nucleus. J Biol Rhythms (1999) 0.95
The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats. Br J Pharmacol (1999) 0.94
Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels. Eur J Pharmacol (1986) 0.94
Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.94
Antagonists of angiotensin. Substitution of an aliphatic chain to phenyl ring in position 8. Rev Can Biol (1971) 0.94
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology (Berl) (2000) 0.94
Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice. Eur J Pharmacol (1997) 0.94
Pharmacological characterization of the vascular permeability enhancing effects of kinins in the rabbit skin. Can J Physiol Pharmacol (1981) 0.93
Receptors for bradykinin in intestinal and uterine smooth muscle. Can J Physiol Pharmacol (1977) 0.93
Pharmacological studies of kinins in venous smooth muscles. Can J Physiol Pharmacol (1981) 0.93
Mechanisms of the cardiovascular effects of neurotensin. Ann N Y Acad Sci (1982) 0.93
Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.93
Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors. Br J Pharmacol (1993) 0.93
Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat. Br J Pharmacol (1992) 0.92
DuP 753 is a specific antagonist for the angiotensin receptor. Hypertension (1991) 0.92
Neurokinin receptors in the rat lower urinary tract. J Pharmacol Exp Ther (1988) 0.92
Role of the C-terminal group for the biological activities of angiotensin. Can J Physiol Pharmacol (1975) 0.92
Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Br J Pharmacol (1994) 0.92